States Opposing Mifepristone Restrictions Tell Court To Send Case To FDA
YAKIMA, Wash. — Washington and other states that sued the U.S. Food and Drug Administration over the agency’s decision to add Risk Evaluation and Mitigation Strategy (REMS) restriction on mifepristone, one...To view the full article, register now.
Already a subscriber? Click here to view full article